Formulation and Evaluation of Sublingual Tablets of Meclizine Hydrochloride
DOI:
https://doi.org/10.61554/ijnrph.v1i2.2023.48Abstract
The aim of the present research is to formulate sublingual tablet of Meclizine Hydrochloride using direct compression method. Moreover the purpose of developing this dosage form is to provide rapid onset of action beneficial in managing conditions of nausea, vomiting and vertigo, and also overcome the problems of solubility of drug by inclusion complexes. The disease like nausea and vomiting required fast onset of action which is necessary for the fast pharmacological action. So, the sublingual route of administration were better way of medication and overcome the problems like dysphagia. The Meclizine hydrochloride is histamine H1 receptor antagonist with antiemetic and antivertigo properties. The oral bioavailability is low (25%), with low solubility (BCS class 2 drug), and metabolized by Hepatic CYP2D6 enzyme by the process of hepatic hydroxylation. Sublingual tablet of antiemetic drug meclizine hydrochloride will be prepared by direct compression method. The Solubility of sublingual tablets will be enhanced by Inclusion complexes. These are prepared by weighed amount of drug mixed with β-cyclodextrin in different dose ratios [1:1,1:2] was wetted with small drops of water to form kneaded like paste and triturated in mortar pestle for several hours resulting in evaporation of solvent. The inclusion complexes was collected and dried for 48 hours and pulverized using mortar and pestle and then sieved through mesh #60. Then properly mixed with other excipients in polybag for 1 hour. The powder like complex was used for further evaluation studies and to form sublingual tablets by direct compression method.
Downloads
Metrics
Keywords:
Meclizine Hydrochloride, Dysphagia, Solubility, Sublingual tablets.Downloads
Published
How to Cite
Issue
Section
References
Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, et al. Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs. Life (Basel) [Internet]. 2023;13(5). Available from: http://dx.doi.org/10.3390/life13051099 DOI: https://doi.org/10.3390/life13051099
George SJ, Vasudevan DT. Studies on the preparation, characterization, and solubility of 2-HP-β-cyclodextrin-meclizine HCI inclusion complexes. J Young Pharm [Internet]. 2012;4(4):220–7. Available from: http://dx.doi.org/10.4103/0975-1483.104365 DOI: https://doi.org/10.4103/0975-1483.104365
Bhide P, Nachinolkar R. Formulation development and characterisation of meclizine hydrochloride fast dissolving tablets using solid dispersion technique. Int J Appl Pharm [Internet]. 2018;10(4):141. Available from: http://dx.doi.org/10.22159/ijap.2018v10i4.26493 DOI: https://doi.org/10.22159/ijap.2018v10i4.26493
Thulluru A, Mahammed N, Madhavi C, Nandini K, Sirisha S, Spandana D. Sublingual tablets-an updated review. Asian J Pharm Res [Internet]. 2019;9(2):97. Available from: http://dx.doi.org/10.5958/2231-5691.2019.00016.9 DOI: https://doi.org/10.5958/2231-5691.2019.00016.9
Sublingual delivery: a promising approach to improve bioavailability. Pharma Science Monitor.
Ponchel G. Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials. Adv Drug Deliv Rev [Internet]. 1994;13(1–2):75–87. Available from: http://dx.doi.org/10.1016/0169-409x(94)90027-2 DOI: https://doi.org/10.1016/0169-409X(94)90027-2
Nikam RS, Borkar SP, D Jadhav P Dr, D. Yadav V, Jadhav A V. Sublingual tablets : An overview. International Journal of Scientific Research in Science and Technology [Internet]. 2020;333–9. Available from: http://dx.doi.org/10.32628/ijsrst207357 DOI: https://doi.org/10.32628/IJSRST207357
An overview on: Sublingual route for systemic drug delivery. Intra-oral Spray Technology.
Pawar PP, Ghorpade HS, Kokane BA. Sublingual route for systemic drug delivery. J Drug Deliv Ther [Internet]. 2018;8(6-s):340–3. Available from: http://dx.doi.org/10.22270/jddt.v8i6-s.2097 DOI: https://doi.org/10.22270/jddt.v8i6-s.2097
Khan AB, Kingsley T, Caroline P. Sublingual tablets and the benefits of the sublingual route of administration. J Pharm Res [Internet]. 2017;16(3):257. Available from: http://dx.doi.org/10.18579/jpcrkc/2017/16/3/118766 DOI: https://doi.org/10.18579/jpcrkc/2017/16/3/118766
Sah S, Badola A, Kothiyal P. Sublingual tablets: an overview. Indian J Pharm Biol Res [Internet]. 2016;4(2):20–6. Available from: http://dx.doi.org/10.30750/ijpbr.4.2.3 DOI: https://doi.org/10.30750/ijpbr.4.2.3
Sharma N, Kumar Sharma T, Chaudhary A, Pandit V, Ashawat MS. A detailed review on fast Dissolving Niosomal Films for sublingual drug delivery. Res J Pharm Dos Forms Technol [Internet]. 2022;163–70. Available from: http://dx.doi.org/10.52711/0975-4377.2022.00026 DOI: https://doi.org/10.52711/0975-4377.2022.00026
Hua S. Advances in Nanoparticulate Drug Delivery Approaches for Sublingual and Buccal Administration. Front Pharmacol [Internet]. 2019;10. Available from: http://dx.doi.org/10.3389/fphar.2019.01328 DOI: https://doi.org/10.3389/fphar.2019.01328
Parkash V, Maan S, Deepika, Yadav S, Hemlata, Jogpal V. Fast disintegrating tablets: Opportunity in drug delivery system. J Adv Pharm Technol Res [Internet]. 2011;2(4):223. Available from: http://dx.doi.org/10.4103/2231-4040.90877 DOI: https://doi.org/10.4103/2231-4040.90877
Goswami T, Jasti BR, Li X. Sublingual drug delivery. Crit Rev Ther Drug Carrier Syst [Internet]. 2008;25(5):449–84. Available from: http://dx.doi.org/10.1615/critrevtherdrugcarriersyst.v25.i5.20 DOI: https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v25.i5.20
Sublingual Drug Delivery System: a Review. Int J Biol Pharm Allied Sci [Internet]. 2022;11(8). Available from: http://dx.doi.org/10.31032/ijbpas/2022/11.8.6271 DOI: https://doi.org/10.31032/IJBPAS/2022/11.8.6271
Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol [Internet]. 2006;117(5):1021–35. Available from: http://dx.doi.org/10.1016/j.jaci.2006.02.040 DOI: https://doi.org/10.1016/j.jaci.2006.02.040
Sem S, Sharma A, Gupta A, Darwhekar GN. Formulation and evaluation of sublingual tablet containing antiemetic drug. J Drug Deliv Ther [Internet]. 2018;8(2). Available from: http://dx.doi.org/10.22270/jddt.v8i2.1680 DOI: https://doi.org/10.22270/jddt.v8i2.1680
International journal of pharmaceutical sciences and research. Vol. 11. International Journal of Pharmaceutical Sciences and Research; 2020.
Formulation and Evaluation of Sublingual Drug Delivery of Ondansetron Hydrochloride Tablets.
Formulation And Evaluation of Orodispersible Tablets of Domperidone from Selected Solid Dispersions-An Attempt to Improve in Vitro Dissolution. Patient Compliance and Marketability.
Kumar MV, Associate Professor, Department of Pharmaceutics, Siddhartha Institute of pharmaceutical sciences, Narasaraopet, Gunturu, India. Formulation and evaluation of meclizine hcl orally dispersible tablets by using natural super disintegrants. Int J Pharma Sci Sci Res [Internet]. 2016;2(1):53–80. Available from: http://dx.doi.org/10.25141/2471-6782-2016-1.0053 DOI: https://doi.org/10.25141/2471-6782-2016-1.0053
Darwesh AY, El-Dahhan MS, Meshali MM. A new dual function orodissolvable/dispersible meclizine HCL tablet to challenge patient inconvenience: in vitro evaluation and in vivo assessment in human volunteers. Drug Deliv Transl Res [Internet]. 2021;11(5):2209–23. Available from: http://dx.doi.org/10.1007/s13346-020-00889-z DOI: https://doi.org/10.1007/s13346-020-00889-z
Londhe VY, Umalkar KB. Formulation development and evaluation of fast dissolving film of telmisartan. Indian J Pharm Sci [Internet]. 2012;74(2):122–6. Available from: http://dx.doi.org/10.4103/0250-474X.10384 DOI: https://doi.org/10.4103/0250-474X.103842
Devi KD, Kumar DDV, Reddy KS. A review on fast dissolving tablets. Int J Pharm Sci Rev Res [Internet]. 2022;71–8. Available from: http://dx.doi.org/10.47583/ijpsrr.2022.v76i02.014 DOI: https://doi.org/10.47583/ijpsrr.2022.v76i02.014
A Novel Method for improving in-vitro dissolution and in-vivo pharmacokinetics of Meclizine hydrochloride.
Vemula SK, Katkum R. Development and physical characterization of meclizine hydrochloride solid dispersions by using polyethylene glycol 8000. Sci Technol Arts Res [Internet]. 2014;3(1):48. Available from: http://dx.doi.org/10.4314/star.v3i1.9 DOI: https://doi.org/10.4314/star.v3i1.9
QbD based Eudragit coated Meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC- Fluorescence detection method.
Development and in vitro Characterization of Meclizine Hydrochloride Solid Dispersions.
Mahrous G, Shazly G, Ibrahim M. Formulation And Evaluation Of Meclizine Hcl Orally Disintegrating Tablets. Bull Pharm Sci [Internet]. 2011;34(2):141–8. Available from: http://dx.doi.org/10.21608/bfsa.2011.63260 DOI: https://doi.org/10.21608/bfsa.2011.63260
Henzi I, Sonderegger J, Tramèr MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth [Internet]. 2000;47(6):537–51. Available from: http://dx.doi.org/10.1007/BF03018945 DOI: https://doi.org/10.1007/BF03018945
Feyer P, Jordan K. Update and new trends in antiemetic therapy: the continuing need for novel therapies. Ann Oncol [Internet]. 2011;22(1):30–8. Available from: http://dx.doi.org/10.1093/annonc/mdq600 DOI: https://doi.org/10.1093/annonc/mdq600
Palliative medicine study group of the Multinational Association of Supportive Care in Cancer. A systematic review of the treatment of nausea and/or vomiting in cancer unrelated to chemotherapy or radiation.
Gill SK, Einarson A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf [Internet]. 2007;6(6):685–94. Available from: http://dx.doi.org/10.1517/14740338.6.6.685 DOI: https://doi.org/10.1517/14740338.6.6.685
